Ramipril 5 mg Capsules is included in the Pill Pass Discount Drug List at Pill Pals Pharmacy. This educational article summarizes key FDA-label topics for patients, caregivers, and prescribers who want a plain-language overview before speaking with a physician or pharmacist.
Drug Name
Ramipril 5 mg Capsules
FDA Labeled Indications
Ramipril is FDA-labeled for hypertension, reduction in risk of myocardial infarction, stroke, and death from cardiovascular causes in high-risk patients, and treatment of stable patients who have shown clinical signs of congestive heart failure after myocardial infarction.
Contraindications
Contraindications include hypersensitivity to ramipril, history of ACE inhibitor-related angioedema, hereditary or idiopathic angioedema, and coadministration with aliskiren in patients with diabetes.
Warnings
Warnings include fetal toxicity in pregnancy, angioedema, low blood pressure, kidney impairment, high potassium, liver failure, neutropenia, and cough.
Precautions
Monitor blood pressure, kidney function, and potassium. Use caution with kidney disease, volume depletion, renal artery stenosis, potassium products, NSAIDs, lithium, and other renin-angiotensin system drugs.
Adverse Reactions
Adverse reactions may include cough, dizziness, low blood pressure, fatigue, headache, high potassium, kidney laboratory changes, and rash.
Pill Pass Discount Drug List Notes
Availability, quantity limits, manufacturer selection, and final dispensing decisions may depend on prescription requirements, clinical appropriateness, inventory, and applicable law. This article is informational and is not a substitute for individualized medical advice, diagnosis, treatment, or the full FDA-approved labeling for the dispensed product.
Related Pill Pass Discount Drug List Articles
For related medications on the same Pill Pass Discount Drug List, you may also review Ramipril 1.25 mg Capsules, Ramipril 2.5 mg Capsules, Ramipril 10 mg Capsules, and Rena-Vite Tablets.
Source note: this article is written as a patient-friendly summary of FDA labeling topics available through DailyMed and related FDA labeling resources. Manufacturer-specific labeling can vary, so patients should rely on the medication guide, package insert, prescriber instructions, and pharmacist counseling for their specific product.
Ramipril 5 mg Capsules is on the Pill Pass List. This information is accurate as of May 13, 2026. If you would like more information on this medication, please contact your Physician or Pharmacist.
